Wagman LD - Search Results

1

Radiofrequency ablation of liver metastases from colorectal carcinoma.

Feliberti EC, Wagman LD. Feliberti EC, et al. Among authors: wagman ld. Cancer Control. 2006 Jan;13(1):48-51. doi: 10.1177/107327480601300107. Cancer Control. 2006. PMID: 16508626 Free article.

2

Pump removal in infected patients with hepatic chemotherapy pumps: when is it necessary?

Roybal JJ, Feliberti EC, Rouse L, Wagman LD. Roybal JJ, et al. Among authors: wagman ld. Am Surg. 2006 Oct;72(10):880-4. Am Surg. 2006. PMID: 17058726

3

Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization.

Artinyan A, Guzman E, Maghami E, Al-Sayed M, D'Apuzzo M, Wagman L, Kim J. Artinyan A, et al. J Clin Oncol. 2008 Aug 20;26(24):4039-41. doi: 10.1200/JCO.2007.15.9038. J Clin Oncol. 2008. PMID: 18711197 No abstract available.

4

Surgical management of hepatic breast cancer metastases.

Podnos YD, Wagman LD. Podnos YD, et al. Among authors: wagman ld. Oncology (Williston Park). 2005 Nov;19(12):1583-7; discussion 1587-8, 1590 passim. Oncology (Williston Park). 2005. PMID: 16396152 Free article. Review.

5

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.

Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU. Wagman LD, et al. J Clin Oncol. 1990 Nov;8(11):1885-93. doi: 10.1200/JCO.1990.8.11.1885. J Clin Oncol. 1990. PMID: 2146370 Clinical Trial.

6

Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

Cahan B, Leong L, Wagman L, Yamauchi D, Shibata S, Wilzcynski S, Williams LE, Yazaki P, Colcher D, Frankel P, Wu A, Raubitschek A, Shively J, Wong JYC. Cahan B, et al. Cancer Biother Radiopharm. 2017 Sep;32(7):258-265. doi: 10.1089/cbr.2017.2223. Cancer Biother Radiopharm. 2017. PMID: 28910150 Free PMC article. Clinical Trial.

7

Ethnic differences in the behavior of hepatocellular carcinoma.

Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD. Chin PL, et al. Among authors: wagman ld. Cancer. 1999 May 1;85(9):1931-6. Cancer. 1999. PMID: 10223232 Clinical Trial.

8

Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization.

Mailey B, Truong C, Artinyan A, Khalili J, Sanchez-Luege N, Denitz J, Marx H, Wagman LD, Kim J. Mailey B, et al. Among authors: wagman ld. J Surg Oncol. 2009 Sep 1;100(3):184-90. doi: 10.1002/jso.21343. J Surg Oncol. 2009. PMID: 19572328

9

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.

Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. Artinyan A, et al. Among authors: wagman ld. Cancer. 2010 Mar 1;116(5):1367-77. doi: 10.1002/cncr.24817. Cancer. 2010. PMID: 20101732 Free article.

10

Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.

Faynsod M, Wagman LD, Longmate J, Carroll M, Leong LA. Faynsod M, et al. Among authors: wagman ld. J Clin Oncol. 2005 Aug 1;23(22):4876-80. doi: 10.1200/JCO.2005.01.515. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009960 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page